Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
Case Rep Oncol ; 17(1): 352-360, 2024.
Article in English | MEDLINE | ID: mdl-38404407

ABSTRACT

Introduction: Rarely solitary sternum metastases are addressed by resection. Two additional cases are presented as they are interesting because of their long-term follow-up. Case Presentation: Case 1: A renal cell carcinoma was treated by transabdominal nephrectomy at age 64. Right iliac bone and sternum metastases were diagnosed 7 months later and treated by internal hemipelvectomy followed by sternum metastasectomy 6 weeks after the internal hemipelvectomy. At 12-year follow-up, the patient appears disease free. Case 2: Prostate cancer was treated by prostatectomy at age 67. A subsequent solitary sternum metastasis was resected 10 years later for persistent PSA-activity despite repeated radiotherapy. The patient remains asymptomatic for 3 years now. Conclusion: Resection of sternum metastases may have curative potential and should be considered in tumours known to be rather resistant to chemo- and/or radiotherapy.

2.
EFORT Open Rev ; 2(2): 51-57, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28461968

ABSTRACT

The treatment of musculoskeletal neoplasms and infection is usually based on an initial diagnostic biopsy.Prior to biopsy, a hypothesis should be formed about the most likely diagnosis and a differential diagnosis. These deliberations should consider whether the lesion is a primary benign or malignant tumour, a metastasis, a haematological problem or an infection.A tactical plan should be developed which evaluates the necessity, the risk, the approach and finally defines the technique of biopsy most likely to achieve a representative result in the clinical case.In developing this technical approach, the pitfalls should be anticipated, i.e. inadequate sampling, difficulty of pathological interpretation and contamination.The tactical approach should be developed in conjunction with a multi-disciplinary team together with appropriate pre-biopsy imaging. Cite this article: EFORT Open Rev 2017;2:51-57. DOI: 10.1302/2058-5241.2.160065.

3.
J Orthop Case Rep ; 6(5): 7-13, 2016.
Article in English | MEDLINE | ID: mdl-28507957

ABSTRACT

INTRODUCTION: Lipoma arborescens (LA) is an uncommon condition that consists of a villous lipomatous proliferation of the synovial membrane. Open synovectomy has been previously selected as a curative treatment option. In recent years, some authors have published good results with arthroscopic interventions. We describe a well-documented case of bilateral LA of the knees treated with staged arthroscopic synovectomy. CASE REPORT: A 48-year-old North American woman without a history of trauma presented with recurrent effusions and mild pain in both knee joints for many years. Magnetic resonance imaging examinations confirmed the diagnosis of bilateral LA with multiple villous lipomatous synovial proliferations pattern. Degenerative changes of the medial meniscus were detected bilaterally. The patient underwent bilateral arthroscopic anterior synovectomy and partial medial meniscectomy of the knee with three portal techniques. Arthroscopic the knee joint contained a large number or finger-shaped synovial proliferations with yellowish good vascularized diffuse villous masses in the suprapatellar bursa and intercondylar fossa. The cartilage showed degenerative changes with Outerbridge Grade II to III, which was particularly severe in the femoropatellar compartment. Histopathological examination of the villous masses demonstrated papillary hypertrophy, slight hyperplasia, vascular hyperplasia with a slight degree of stromal fibrosis, and interstitial lymphoplasmacytic inflammation. The adipose cells were reduced in number in relation to a normal finding but had a normal aspect without any pathological changes. 25 months after the first operation, the patient reported pain relief with the preserved function. Magnetic resonance examination of both knee joints at the last follow-up showed no relapse of the disease. The Knee injury and Osteoarthritis Outcome Score improved on the right knee joint from 39.3 preoperatively to 85.1 at the last follow-up, and on the left knee joint from 54.2 preoperatively to 86.3 at the last follow-up. CONCLUSION: Arthroscopic anterior synovectomy is an efficient method of achieving good results in LA with multiple villous lipomatous synovial proliferations pattern.

4.
J Thorac Oncol ; 10(10): 1383-95, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26295375

ABSTRACT

This overview of the 4th edition of the World Health Organization (WHO) Classification of thymic tumors has two aims. First, to comprehensively list the established and new tumor entities and variants that are described in the new WHO Classification of thymic epithelial tumors, germ cell tumors, lymphomas, dendritic cell and myeloid neoplasms, and soft-tissue tumors of the thymus and mediastinum; second, to highlight major differences in the new WHO Classification that result from the progress that has been made since the 3rd edition in 2004 at immunohistochemical, genetic and conceptual levels. Refined diagnostic criteria for type A, AB, B1-B3 thymomas and thymic squamous cell carcinoma are given, and it is hoped that these criteria will improve the reproducibility of the classification and its clinical relevance. The clinical perspective of the classification has been strengthened by involving experts from radiology, thoracic surgery, and oncology; by incorporating state-of-the-art positron emission tomography/computed tomography images; and by depicting prototypic cytological specimens. This makes the thymus section of the new WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart a valuable tool for pathologists, cytologists, and clinicians alike. The impact of the new WHO Classification on therapeutic decisions is exemplified in this overview for thymic epithelial tumors and mediastinal lymphomas, and future perspectives and challenges are discussed.


Subject(s)
Thymoma/classification , Thymus Neoplasms/classification , Humans , Neoplasm Grading , Neoplasm Staging , Thymoma/pathology , Thymus Neoplasms/pathology , World Health Organization
5.
J Thorac Oncol ; 9(5): 596-611, 2014 May.
Article in English | MEDLINE | ID: mdl-24722150

ABSTRACT

INTRODUCTION: The 2004 version of the World Health Organization classification subdivides thymic epithelial tumors into A, AB, B1, B2, and B3 (and rare other) thymomas and thymic carcinomas (TC). Due to a morphological continuum between some thymoma subtypes and some morphological overlap between thymomas and TC, a variable proportion of cases may pose problems in classification, contributing to the poor interobserver reproducibility in some studies. METHODS: To overcome this problem, hematoxylin-eosin-stained and immunohistochemically processed sections of prototypic, "borderland," and "combined" thymomas and TC (n = 72) were studied by 18 pathologists at an international consensus slide workshop supported by the International Thymic Malignancy Interest Group. RESULTS: Consensus was achieved on refined criteria for decision making at the A/AB borderland, the distinction between B1, B2, and B3 thymomas and the separation of B3 thymomas from TCs. "Atypical type A thymoma" is tentatively proposed as a new type A thymoma variant. New reporting strategies for tumors with more than one histological pattern are proposed. CONCLUSION: These guidelines can set the stage for reproducibility studies and the design of a clinically meaningful grading system for thymic epithelial tumors.


Subject(s)
Carcinoma/pathology , Thymoma/pathology , Thymus Neoplasms/pathology , Antigens, CD20/analysis , CD5 Antigens/analysis , Carcinoma/chemistry , Glucose Transporter Type 1/analysis , Humans , Mucin-1/analysis , Proto-Oncogene Proteins c-kit/analysis , Reproducibility of Results , Thymoma/chemistry , Thymus Neoplasms/chemistry , World Health Organization
6.
Eur Heart J ; 35(40): 2839-48, 2014 Oct 21.
Article in English | MEDLINE | ID: mdl-24419805

ABSTRACT

AIMS: Lectin-like oxLDL receptor-1 (LOX-1) mediates the uptake of oxidized low-density lipoprotein (oxLDL) in endothelial cells and macrophages. However, the different atherogenic potential of LOX-1-mediated endothelial and macrophage oxLDL uptake remains unclear. The present study was designed to investigate the in vivo role of endothelial LOX-1 in atherogenesis. METHODS AND RESULTS: Endothelial-specific LOX-1 transgenic mice were generated using the Tie2 promoter (LOX-1TG). Oxidized low-density lipoprotein uptake was enhanced in cultured endothelial cells, but not in macrophages of LOX-1TG mice. Six-week-old male LOX-1TG and wild-type (WT) mice were fed a high-cholesterol diet (HCD) for 30 weeks. Increased reactive oxygen species production, impaired endothelial nitric oxide synthase activity and endothelial dysfunction were observed in LOX-1TG mice as compared with WT littermates. LOX-1 overexpression led to p38 phosphorylation, increased nuclear factor κB activity and subsequent up-regulation of vascular cell adhesion molecule-1, thereby favouring macrophage accumulation and aortic fatty streaks. Consistently, HCD-fed double-mutant LOX-1TG/ApoE(-/-) displayed oxidative stress and vascular inflammation with higher aortic plaques than ApoE(-/-) controls. Finally, bone marrow transplantation experiments showed that endothelial LOX-1 was sufficient for atherosclerosis development in vivo. CONCLUSIONS: Endothelial-specific LOX-1 overexpression enhanced aortic oxLDL levels, thereby favouring endothelial dysfunction, vascular inflammation and plaque formation. Thus, LOX-1 may serve as a novel therapeutic target for atherosclerosis.


Subject(s)
Atherosclerosis/etiology , Endothelium, Vascular/metabolism , Scavenger Receptors, Class E/metabolism , Animals , Aorta, Abdominal/metabolism , Aorta, Thoracic/metabolism , Aortitis/etiology , Apolipoproteins E/metabolism , Cells, Cultured , Cholesterol, Dietary/administration & dosage , Male , Mice, Transgenic , Plaque, Atherosclerotic/etiology , Reactive Oxygen Species/metabolism
7.
Virchows Arch ; 462(6): 609-17, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23588556

ABSTRACT

The source of precursor lesions of squamous cell carcinoma (SCC) of the oral cavity and pharynx, their classification, and grading are controversial. In contrast, vulvar and penile cancer precursor lesions are known to be related to human papillomavirus or chronic inflammation and can be described using the vulvar intraepithelial neoplasia (VIN) classification system (VIN 1-3) or as differentiated vulvar intraepithelial neoplasia (dVIN), respectively. Oral and pharyngeal SCC precursor lesions are more etiologically diverse, and the spectrum of lesions may thus be wider. No international consensus exists regarding the histological types of precursor lesions or the significance of individual types. We therefore reviewed resection specimens and preceding biopsies of 155 patients with SCC of the oral cavity and pharynx (excluding tonsils) and identified five basic patterns of SCC-associated or precursor lesions: (1) pleomorphic (22/155), (2) basaloid (5/155), (3) differentiated (63/155), (4) mixed (42/155), and (5) verrucous (12/155). Keratinization was a common but variable feature in differentiated, mixed, and verrucous dysplasia. In 11/155 patients, no precursor lesion could be identified. Progression of isolated differentiated dysplasia (ranging from months to years) was documented in 13/155 (8 %) of patients. Our data suggest that full-thickness epithelial dysplasia of pleomorphic or basaloid type is present in <20 % of oral and pharyngeal SCC, and differentiated dysplasia is a frequent precursor or associated in situ lesion. Failure to recognize differentiated dysplasia results in the underdiagnosis of many patients at risk for invasive carcinoma. These results indicate a need to refine criteria to distinguish differentiated dysplasia from morphologically related lichenoid lesions.


Subject(s)
Carcinoma, Squamous Cell/pathology , Mouth Neoplasms/pathology , Pharyngeal Neoplasms/pathology , Precancerous Conditions/pathology , Databases, Factual , Disease Progression , Female , Humans , Lichenoid Eruptions/pathology , Male , Middle Aged , Neoplasm Invasiveness , Retrospective Studies
8.
Eur J Immunol ; 43(3): 716-22, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23254454

ABSTRACT

Interleukin (IL)-1α is a potent proinflammatory cytokine that has been implicated in the development of atherosclerosis. We investigated whether a vaccine inducing IL-1α neutralizing antibodies could interfere with disease progression in a murine model of atherosclerosis. We immunized Apolipoprothin E (ApoE)-deficient mice with a vaccine (IL-1α-C-Qß) consisting of full-length, native IL-1α chemically conjugated to virus-like particles derived from the bacteriophage Qß. ApoE(-/-) mice were administered six injections of IL-1α-C-Qß or nonconjugated Qß over a period of 160 days while being maintained on a western diet. Atherosclerosis was measured in the descending aorta and in cross-sections at the aortic root. Macrophage infiltration in the aorta was measured using CD68. Expression levels of VCAM-1, ICAM-1, and MCP-1 were quantified by RT-PCR. Immunization against IL-1α reduced plaque progression in the descending aorta by 50% and at the aortic root by 37%. Macrophage infiltration in the aorta was reduced by 22%. Inflammation was also reduced in the adventitia, with a decrease of 54% in peri-aortic infiltrate score and reduced expression levels of VCAM-1 and ICAM-1. Active immunization targeting IL-1α reduced both the inflammatory reaction in the plaque as well as plaque progression. In summary, vaccination against IL-1α protected ApoE(-/-) mice against disease, suggesting that this may be a potential treatment option for atherosclerosis.


Subject(s)
Atherosclerosis/immunology , Interleukin-1alpha/immunology , Vaccines, Virus-Like Particle/immunology , Animals , Antibodies/immunology , Antibodies, Neutralizing/immunology , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Atherosclerosis/genetics , Atherosclerosis/prevention & control , Inflammation/genetics , Inflammation/immunology , Inflammation/metabolism , Male , Mice , Mice, Knockout , Plaque, Atherosclerotic/genetics , Plaque, Atherosclerotic/immunology , Plaque, Atherosclerotic/pathology , Vaccines, Virus-Like Particle/administration & dosage
9.
Mod Pathol ; 25(7): 1048-53, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22481282

ABSTRACT

Tumor budding, a histological hallmark of epithelial-mesenchymal transition in colorectal cancer, is a parameter of tumor progression and according to the International Union Against Cancer/American Joint Committee on Cancer an 'additional' prognostic factor. The current definition of tumor budding is reserved for the invasive tumor front of colorectal cancer (so called peri-tumoral budding), but tumor buds can also be observed in small preoperative biopsy specimens. Whereas the prognostic value of peri-tumoral budding assessed in resection specimens has found wide acceptance, the value of budding in preoperative biopsies, which normally do not encompass the invasive tumor margin and hence can be called intra-tumoral budding, has not been systematically investigated yet. Therefore, the aim of this study is to assess the predictive value of intra-tumoral budding for lymph node and distant metastasis in preoperative biopsies. Preoperative biopsy samples and consecutive resection specimens from 72 patients with pathological information on TNM stage, vascular, lymphatic and perineural invasion, and tumor border configuration were used to evaluate intra-tumoral budding and peri-tumoral budding. Both parameters were scored semiquantitatively as 'high' (detectable at low power magnification × 2.5) and 'low' (occasional budding at intermediate magnification × 10, difficult to find or absent). In biopsy samples high intra-tumoral budding was observed in 12/72 patients (17%) and associated with high peri-tumoral budding in the corresponding resection specimens (P=0.008). Additionally, there was a correlation between high intra-tumoral budding and lymph node metastasis (P=0.034), distant metastasis (P=0.007) and higher tumor grade (P=0.025). Peri-tumoral budding was associated with higher N stage (P=0.004), vascular (P=0.046) and lymphatic invasion (P=0.019) as well as with an infiltrating tumor border (P<0.001), reflecting the predictive power of peri-tumoral budding for tumor progression. High intra-tumoral budding in preoperative biopsy samples of colorectal cancer patients predicts high peri-tumoral budding at the invasive margin and lymph node metastasis in the corresponding resection specimens as well as distant metastasis.


Subject(s)
Adenocarcinoma/secondary , Colorectal Neoplasms/pathology , Epithelial-Mesenchymal Transition , Lymphatic Metastasis/pathology , Neoplasm Staging/methods , Adult , Aged , Aged, 80 and over , Biopsy , Female , Humans , Lymph Nodes/pathology , Male , Middle Aged , Neoplasm Grading , Predictive Value of Tests
11.
PLoS One ; 4(9): e7160, 2009 Sep 25.
Article in English | MEDLINE | ID: mdl-19779609

ABSTRACT

The susceptibility of humans and animals to prion infections is determined by the virulence of the infectious agent, by genetic modifiers, and by hitherto unknown host and environmental risk factors. While little is known about the latter two, the activation state of the immune system was surmised to influence prion susceptibility. Here we administered prions to mice that were repeatedly immunized by two initial injections of CpG oligodeoxynucleotides followed by repeated injections of bovine serum albumin/alum. Immunization greatly reduced the required dosage of peripherally administered prion inoculum necessary to induce scrapie in 50% of mice. No difference in susceptibility was observed following intracerebral prion challenge. Due to its profound impact onto scrapie susceptibility, the host immune status may determine disease penetrance after low-dose prion exposure, including those that may give rise to iatrogenic and variant Creutzfeldt-Jakob disease.


Subject(s)
Immunization/methods , Prions/metabolism , Scrapie/prevention & control , Animals , Cattle , CpG Islands , Creutzfeldt-Jakob Syndrome/prevention & control , Disease Susceptibility , Female , In Situ Hybridization , Mice , Mice, Inbred C57BL , Oligonucleotides/chemistry , Risk Factors , Serum Albumin, Bovine/chemistry
12.
Proc Natl Acad Sci U S A ; 106(28): 11673-8, 2009 Jul 14.
Article in English | MEDLINE | ID: mdl-19564598

ABSTRACT

Suppression by natural CD4(+)CD25(+) regulatory T cells (Tregs) is one mechanism by which tolerance is maintained. However, the way in which Tregs mediate suppression is not well understood. Here, we show that secreted phospholipase A2 (sPLA2)-IID is selectively produced by Tregs. sPLA2-IID is a potent mediator of Treg function, because it strongly suppressed proliferation of CD4(+) and CD8(+) T cells in vitro and in vivo in a manner independent of its catalytic activity. Furthermore, sPLA2-IID promoted the differentiation of Tregs, presumably via attenuating signaling through the PI3K/Akt/mammalian target of rapamycin pathway. Importantly, administration of a sPLA2-IID-Fc fusion protein inhibited disease development in murine models of colitis and multiple sclerosis, suggesting that sPLA2-IID's immunosuppressive function might be exploited therapeutically.


Subject(s)
Cell Differentiation/immunology , Cell Proliferation/drug effects , Colitis/prevention & control , Group II Phospholipases A2/pharmacology , Multiple Sclerosis/prevention & control , Signal Transduction/immunology , T-Lymphocytes, Regulatory/metabolism , Adoptive Transfer , Animals , Cell Differentiation/drug effects , Colitis/immunology , DNA Primers/genetics , Flow Cytometry , Group II Phospholipases A2/metabolism , Mice , Multiple Sclerosis/immunology , Recombinant Fusion Proteins/pharmacology , Reverse Transcriptase Polymerase Chain Reaction
13.
Immunity ; 29(6): 998-1008, 2008 Dec 19.
Article in English | MEDLINE | ID: mdl-19100703

ABSTRACT

Prior to invading the nervous system, prions frequently colonize lymphoid organs and sites of inflammatory lymphoneogenesis, where they colocalize with Mfge8+ follicular dendritic cells (FDCs). Here, we report that soft-tissue granulomas, a frequent feature of chronic inflammation, expressed the cellular prion protein (PrPC, encoded by Prnp) and the lymphotoxin receptor (LTbetaR), even though they lacked FDCs and did not display lymphoneogenesis. After intraperitoneal prion inoculation, granulomas of Prnp(+/+) mice, but not Prnp(-/-) granulomas or unaffected Prnp(+/+) skin, accumulated prion infectivity and disease-associated prion protein. Bone-marrow transfers between Prnp(+/+) and Prnp(-/-) mice and administration of lymphotoxin signaling antagonists indicated that prion replication required radioresistant PrPC-expressing cells and LTbetaR signaling. Granulomatous PrPC was mainly expressed by stromal LTbetaR+ mesenchymal cells that were absent from unaffected subcutis. Hence, granulomas can act as clinically silent reservoirs of prion infectivity. Furthermore, lymphotoxin-dependent prion replication can occur in inflammatory stromal cells that are distinct from FDCs.


Subject(s)
Dendritic Cells, Follicular/immunology , Granuloma/immunology , Lymphotoxin beta Receptor/immunology , Lymphotoxin-alpha/immunology , Prions/metabolism , Animals , Dendritic Cells, Follicular/metabolism , Granuloma/genetics , Granuloma/pathology , Lymphotoxin beta Receptor/metabolism , Lymphotoxin-alpha/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Prion Proteins , Prions/genetics , Stromal Cells/immunology , Stromal Cells/metabolism
14.
Arterioscler Thromb Vasc Biol ; 28(3): 504-10, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18174455

ABSTRACT

OBJECTIVE: Sepsis is a major cause of death for intensive care patients. High concentrations of inflammatory cytokines are characteristic of severe systemic inflammation and activated monocytes are their predominant cellular source. To identify targets for antiinflammatory intervention, we investigated the response of human macrophages to inflammatory and antiinflammatory mediators. METHODS AND RESULTS: We profiled gene expression in human macrophages exposed to lipopolysaccharide (LPS) and interferon (IFN)-gamma in the presence or absence of recombinant activated protein C (APC) or IL-10 and identified Wnt5A as one of the transcripts most highly induced by LPS/IFN-gamma and suppressed by APC and IL-10. We confirmed regulation of Wnt5A protein in macrophages and detected it in sera and bone marrow macrophages of patients with severe sepsis. We established that a functional Wnt5A/frizzled-5/CaMKII signaling pathway was essential for macrophage inflammatory activation. To prove the essential contribution of Wnt5A we measured inflammatory cytokines after stimulation with Wnt5A, silenced Wnt5A by siRNA, and blocked receptor binding with soluble Frizzled-related peptide-1 (sFRP1). CONCLUSIONS: Wnt5A is critically involved in inflammatory macrophage signaling in sepsis and is a target for antiinflammatory mediators like APC or antagonists like sFRP1.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Interleukin-10/metabolism , Protein C/metabolism , Proto-Oncogene Proteins/metabolism , Signal Transduction/drug effects , Wnt Proteins/metabolism , Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics , Cell Communication , Cells, Cultured , Gene Expression Profiling , Humans , Inflammation/physiopathology , Inflammation Mediators/analysis , Interferon-gamma/pharmacology , Lipopolysaccharides/pharmacology , Macrophage Activation/drug effects , Macrophages/cytology , Macrophages/drug effects , Phosphorylation , Proto-Oncogene Proteins/genetics , RNA, Messenger/analysis , Sensitivity and Specificity , Sepsis/physiopathology , Signal Transduction/genetics , Wnt Proteins/genetics , Wnt-5a Protein
15.
Clin Sci (Lond) ; 114(1): 49-58, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17608625

ABSTRACT

Glaucoma, frequently associated with high IOP (intra-ocular pressure), is a leading cause of blindness, characterized by a loss of retinal ganglion cells and the corresponding optic nerve fibres. In the present study, acutely and transiently elevated IOP, characteristic of acute angle-closure glaucoma in humans, was observed in CLR (calcitonin receptor-like receptor) transgenic mice between 1 and 3 months of age. Expression of CLR under the control of a smooth muscle alpha-actin promoter in these mice augmented signalling of the smooth-muscle-relaxing peptide adrenomedullin in the pupillary sphincter muscle and resulted in pupillary palsy. Elevated IOP was prevented in CLR transgenic mice when mated with hemizygote adrenomedullin-deficient mice with up to 50% lower plasma and organ adrenomedullin concentrations. This indicates that endogenous adrenomedullin of iris ciliary body origin causes pupillary palsy and angle closure in CLR transgenic mice overexpressing adrenomedullin receptors in the pupillary sphincter muscle. In human eyes, immunoreactive adrenomedullin has also been detected in the ciliary body. Furthermore, the CLR and RAMP2 (receptor-activity-modifying protein 2), constituting adrenomedullin receptor heterodimers, were identified in the human pupillary sphincter muscle. Thus, in humans, defective regulation of adrenomedullin action in the pupillary sphincter muscle, provoked in the present study in CLR transgenic mice, may cause acute and chronic atony and, thereby, contribute to the development of angle-closure glaucoma. The CLR transgenic mice used in the present study provide a model for acute angle-closure glaucoma.


Subject(s)
Disease Models, Animal , Glaucoma, Angle-Closure/metabolism , Receptors, Peptide/metabolism , Acute Disease , Animals , Base Sequence , Calcitonin Receptor-Like Protein , Ciliary Body/metabolism , Eye Proteins/genetics , Glaucoma, Angle-Closure/etiology , Glaucoma, Angle-Closure/genetics , Glaucoma, Angle-Closure/physiopathology , Humans , Intraocular Pressure , Iris/physiopathology , Iris Diseases/complications , Iris Diseases/metabolism , Iris Diseases/physiopathology , Membrane Glycoproteins/genetics , Mice , Mice, Transgenic , Mutation , Oxidoreductases/genetics , Receptors, Adrenomedullin , Receptors, Calcitonin/metabolism , Receptors, Calcitonin/physiology
16.
J Autoimmun ; 28(4): 224-33, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17336498

ABSTRACT

Autoimmune responses directed against heart-specific antigens most likely play a key role in the pathogenesis of myocarditis. Although autoantibodies against cardiac determinants are frequently detected both in human patients and mice suffering from myocarditis, the immunological mechanisms for their induction have not yet been fully explored. We used here the SEREX approach (serological identification of recombinantly expressed proteins) to molecularly dissect heart-specific autoimmune B cell responses that develop in the course of experimentally induced myocarditis. Screening of a heart cDNA library with sera of cardiac myosin heavy chain alpha (myhcalpha) peptide-immunized BALB/c mice revealed a strong focusing of the B cell response on the myhcalpha protein. The vast majority of the myhcalpha transcripts coded for regions other than the sequence of the immunogenic myhcalpha peptide, indicating extensive intramolecular epitope spreading. Importantly, we found that the infection with cardiotropic viruses such as MCMV and Coxsackievirus B3 elicited specific autoantibody pattern with a particular skewing to the myhcalpha protein. The induction of myhcalpha peptide-specific Th cells in the course of both infections suggests that infection-associated determinant spreading on the Th cell level paves the way for a focused and dominant anti-myhcalpha B cell response.


Subject(s)
Autoantibodies/immunology , Autoimmune Diseases/immunology , B-Lymphocytes/immunology , Myocarditis/immunology , Myocardium/immunology , Myosin Heavy Chains/immunology , Animals , Autoimmune Diseases/pathology , Autoimmune Diseases/virology , B-Lymphocytes/pathology , Enterovirus B, Human/immunology , Enterovirus Infections/immunology , Enterovirus Infections/pathology , Epitopes, B-Lymphocyte/immunology , Herpesviridae Infections/immunology , Herpesviridae Infections/pathology , Humans , Mice , Mice, Inbred BALB C , Mice, Knockout , Muromegalovirus/immunology , Myocarditis/pathology , Myocarditis/virology , Organ Specificity/immunology , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Helper-Inducer/pathology
17.
Proc Natl Acad Sci U S A ; 104(8): 2861-6, 2007 Feb 20.
Article in English | MEDLINE | ID: mdl-17299038

ABSTRACT

Pancreatic beta cell mass and function increase in conditions of enhanced insulin demand such as obesity. Failure to adapt leads to diabetes. The molecular mechanisms controlling this adaptive process are unclear. Fas is a death receptor involved in beta cell apoptosis or proliferation, depending on the activity of the caspase-8 inhibitor FLIP. Here we show that the Fas pathway also regulates beta cell secretory function. We observed impaired glucose tolerance in Fas-deficient mice due to a delayed and decreased insulin secretory pattern. Expression of PDX-1, a beta cell-specific transcription factor regulating insulin gene expression and mitochondrial metabolism, was decreased in Fas-deficient beta cells. As a consequence, insulin and ATP production were severely reduced and only partly compensated for by increased beta cell mass. Up-regulation of FLIP enhanced NF-kappaB activity via NF-kappaB-inducing kinase and RelB. This led to increased PDX-1 and insulin production independent of changes in cell turnover. The results support a previously undescribed role for the Fas pathway in regulating insulin production and release.


Subject(s)
Insulin-Secreting Cells/metabolism , fas Receptor/metabolism , Animals , Blood Glucose , CASP8 and FADD-Like Apoptosis Regulating Protein/metabolism , Fas Ligand Protein/genetics , Fas Ligand Protein/metabolism , Gene Expression Regulation , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Insulin/genetics , Insulin/metabolism , Insulin-Secreting Cells/cytology , Male , Mice , Mice, Inbred C57BL , Mitochondria/metabolism , NF-kappa B/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Trans-Activators/genetics , Trans-Activators/metabolism , fas Receptor/deficiency , fas Receptor/genetics
18.
J Clin Invest ; 116(10): 2817-26, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17016562

ABSTRACT

T cell activation by APCs is positively and negatively regulated by members of the B7 family. We have identified a previously unknown function for B7 family-related protein V-set and Ig domain-containing 4 (VSIG4). In vitro experiments using VSIG4-Ig fusion molecules showed that VSIG4 is a strong negative regulator of murine and human T cell proliferation and IL-2 production. Administration to mice of soluble VSIG4-Ig fusion molecules reduced the induction of T cell responses in vivo and inhibited the production of Th cell-dependent IgG responses. Unlike that of B7 family members, surface expression of VSIG4 was restricted to resting tissue macrophages and absent upon activation by LPS or in autoimmune inflammatory foci. The specific expression of VSIG4 on resting macrophages in tissue suggests that this inhibitory ligand may be important for the maintenance of T cell unresponsiveness in healthy tissues.


Subject(s)
Immunoglobulins/physiology , Lymphocyte Activation/immunology , Receptors, Complement/physiology , T-Lymphocytes/immunology , Amino Acid Sequence , Animals , Autoimmune Diseases/chemically induced , Autoimmune Diseases/immunology , Autoimmune Diseases/metabolism , B7-1 Antigen/pharmacology , B7-H1 Antigen , Cell Line , Cell Proliferation/drug effects , Female , Gene Expression/drug effects , Gene Expression/immunology , Humans , Immunoglobulins/genetics , Immunoglobulins/pharmacology , Interferon-gamma/metabolism , Interleukin-2/metabolism , Interleukin-2/pharmacology , Lipopolysaccharides/pharmacology , Liver/cytology , Liver/metabolism , Lymphocyte Activation/drug effects , Macrophages/drug effects , Macrophages/metabolism , Membrane Glycoproteins/pharmacology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Molecular Sequence Data , Myocarditis/chemically induced , Myocarditis/immunology , Myocarditis/metabolism , Peptides/pharmacology , Programmed Cell Death 1 Ligand 2 Protein , Receptors, Complement/genetics , Receptors, Complement/metabolism , Sequence Homology, Amino Acid , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , Thioglycolates/pharmacology
19.
Eur J Haematol ; 77(5): 432-6, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17044836

ABSTRACT

OBJECTIVES: Uncontrolled macrophage activation with hemophagocytosis is a distinctive feature of hemophagocytic syndromes (HPS). We examined whether lympho-histiocytic infiltration of the bone marrow and liver, as well as hemo-/erythrophagocytosis also occurs during sepsis and whether this process could account for the increased production of anti-inflammatory heme-oxygenase (HO-1) products observed during sepsis. METHODS: Hemophagocytosis and expression of CD163, HO-1, ferritin as well as CD8 and granzyme-B were examined in post-mortem bone marrow samples from 28 patients with sepsis and from eight control patients. RESULTS: Comparison of samples from non-septic patients with samples from patients with fatal sepsis revealed that the latter group displayed dense lympho-histiocytic bone marrow infiltration with CD163(+)/HO-1(+)/ferritin(+) macrophages as well as with CD8(+) and granzyme-B(+) T-cells. Hemophagocytosis with prominent phagocytosis of erythroid cells was readily apparent in septic patients, implying that this process is a likely stimulus for the up-regulation of macrophage HO-1 expression. CONCLUSIONS: Lympho-histiocytic activation with hemophagocytosis is a shared pathophysiologic mechanism in HPS and sepsis. Furthermore, the association of hemophagocytosis with an increase in HO-1 expression may indicate a novel role for this apparently futile process as a negative regulator of inflammation.


Subject(s)
Gene Expression Regulation, Enzymologic , Heme Oxygenase-1/biosynthesis , Macrophages/enzymology , Phagocytosis , Sepsis/enzymology , Up-Regulation , Adult , Aged , Aged, 80 and over , Biomarkers/metabolism , Bone Marrow/enzymology , Bone Marrow/metabolism , Bone Marrow/pathology , Erythroid Cells/enzymology , Erythroid Cells/pathology , Female , Gene Expression Regulation, Enzymologic/genetics , Heme Oxygenase-1/genetics , Humans , Liver/enzymology , Liver/pathology , Macrophages/pathology , Male , Middle Aged , Phagocytosis/genetics , Sepsis/genetics , Sepsis/pathology , Up-Regulation/genetics
20.
Proc Natl Acad Sci U S A ; 103(43): 15951-6, 2006 Oct 24.
Article in English | MEDLINE | ID: mdl-17038503

ABSTRACT

Because of species selectivity, HIV research is largely restricted to in vitro or clinical studies, both limited in their ability to rapidly assess new strategies to fight the virus. To prospectively study some aspects of HIV in vivo, immunodeficient mice, transplanted with either human peripheral blood leukocytes or human fetal tissues, have been developed. Although these are susceptible to HIV infection, xenoreactivity, and short infection spans, resource and ethical constraints, as well as biased HIV coreceptor tropic strain infection, pose substantial problems in their use. Rag2(-/-)gamma(c)(-/-) mice, transplanted as newborns with human CD34(+) cells, were recently shown to develop human B, T, and dendritic cells, constituting lymphoid organs in situ. Here we tested these mice as a model system for HIV-1 infection. HIV RNA levels peaked to up to 2 x 10(6) copies per milliliter of plasma early after infection, and viremia was observed for up to 190 days, the longest time followed. A marked relative CD4(+) T cell depletion in peripheral blood occurred in CXCR4-tropic strain-infected mice, whereas this was less pronounced in CCR5-tropic strain-infected animals. Thymus infection was almost exclusively observed in CXCR4-tropic strain-infected mice, whereas spleen and lymph node HIV infection occurred irrespective of coreceptor selectivity, consistent with respective coreceptor expression on human CD4(+) T cells. Thus, this straightforward to generate and cost-effective in vivo model closely resembles HIV infection in man and therefore should be valuable to study virus-induced pathology and to rapidly evaluate new approaches aiming to prevent or treat HIV infection.


Subject(s)
Antigens, CD34/analysis , Cord Blood Stem Cell Transplantation , DNA-Binding Proteins/deficiency , HIV Infections/immunology , HIV Infections/virology , HIV-1/immunology , Receptors, Antigen, T-Cell, gamma-delta/deficiency , Animals , B-Lymphocytes/immunology , B-Lymphocytes/virology , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , HIV Infections/metabolism , HIV Infections/surgery , Humans , Lymphoid Tissue/immunology , Lymphoid Tissue/metabolism , Lymphoid Tissue/virology , Mice , Mice, Knockout , Receptors, Antigen, T-Cell, gamma-delta/genetics , Receptors, Antigen, T-Cell, gamma-delta/metabolism , Receptors, CCR5/immunology , Receptors, CCR5/metabolism , Receptors, CXCR4/immunology , Receptors, CXCR4/metabolism , Thymus Gland/immunology , Thymus Gland/metabolism , Thymus Gland/pathology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...